CLIA Waived 10 Panel Drug Test Cup with Fentanyl 1 ng/mL

CLIA Waived 10 Panel Drug Test Cup with Fentanyl 1 ng/mL

The CLIA waived 10 panel drug test cup combines urine collection and 10 preliminary drug screens in one 120 mL device. It is built for programs that want fentanyl screening without moving to a larger, more expensive panel.

Fentanyl is screened at 1 ng/mL alongside the opioid panels most often used in treatment monitoring: opiates, oxycodone, methadone and buprenorphine. Amphetamine, cocaine, methamphetamine, benzodiazepines and THC complete the menu.

Buyers comparing panel sizes can review our 10 panel vs. 12 panel drug test guide or browse all 10 panel drug test cups.

10 Panel Drug Test List and Cutoff Levels

Compare both the target and the cutoff when choosing a configuration. Products with a similar name or panel count can use different cutoff levels.

Serenity 120 mL Click Cup Features

The click-top lid is designed to close securely and help prevent leaks. A built-in temperature strip provides a specimen-temperature reference shortly after collection.

Because all 10 panels are built into the cup, collection and screening happen in one device without transferring the specimen.

A 10 panel configuration keeps the per-test cost lower than larger cups while still covering fentanyl and the main opioid classes.

Fentanyl, Buprenorphine and Methadone Panels

The opioid panels make this cup a practical choice for medication-assisted treatment and recovery programs.

BUP/10 screens for buprenorphine, which is commonly monitored in medication-assisted treatment programs.

FEN/1 is a dedicated fentanyl assay. Fentanyl is a synthetic opioid that a standard OPI (morphine) panel is not designed to detect, so a separate fentanyl panel is needed when fentanyl screening is required.

MTD/300 screens for methadone, which is commonly monitored in opioid treatment programs.

OXY/100 screens for oxycodone, a semi-synthetic opioid that standard opiate panels may not detect at typical cutoffs.

How to Use and Read Results

Always follow the package insert supplied with the exact lot, because collection steps and reading times can differ between devices.

1. Bring the sealed cup and the specimen to room temperature as directed in the package insert.
2. Collect urine directly into the cup to the required level and close the lid securely.
3. Check the built-in temperature strip within the time stated in the insert.
4. Activate or expose the test panels as directed and start timing.
5. Read each panel within the interpretation window stated in the insert; do not read results after that window.

• Negative: both the control line (C) and the test line (T) appear for each panel. A faint test line is interpreted according to the insert.
• Non-negative (preliminary positive): the control line appears but the test line does not. This is a preliminary screening result, not a confirmed result.
• Invalid: no control line appears. Do not interpret the result; repeat the test with a new device.

A non-negative screen should be followed by laboratory confirmation according to your program’s procedure before any final decision is made. A screening result does not show impairment, dose or the time of use.

For a step-by-step explanation of line-based results, see our guide on how to read a drug test cup.

Who Uses This CLIA Waived 10 Panel Cup?

This 10 panel drug test cup is labeled CLIA-waived. Typical buyers include:

• Physician offices, urgent care and occupational health clinics
• Addiction treatment, MAT and recovery programs
• Employers and third-party administrators running non-DOT programs
• Community and public-health testing programs

A CLIA-waived test still has to be performed under the appropriate CLIA certificate. See the CMS CLIA program and our guide to CLIA-waived vs. non-waived tests.

Intended Use, Storage & Limitations

This cup is labeled CLIA-waived. CLIA status belongs to the specific test system, so it should not be assumed for other products with a similar name or panel count.

Store sealed pouches as directed on the packaging, check the expiration date before use and use each device only once.

This is a preliminary screening test: it detects only the targets listed above at the stated cutoffs. As the FDA guidance on drugs-of-abuse screening tests explains, preliminary positive results should be confirmed by a laboratory. Instant tests are not an authorized method for DOT-regulated drug testing under 49 CFR §40.210.

Bulk & Wholesale CLIA Waived 10 Panel Drug Test Cups

DrugTestingCup.com sells the CLIA waived 10 panel drug test cup with quantity-based pricing: the larger the order, the lower the price per cup. FREE SHIPPING applies to orders of 100 cups or more, and eligible in-stock orders placed before 3 PM EST ship the same business day.

Treatment programs, correctional facilities, clinics, resellers and distributors with recurring or high-volume orders can contact our team for wholesale pricing. Before ordering, compare other options in our CLIA-waived drug test cups.

Frequently Asked Questions

What does this CLIA waived 10 panel drug test cup screen for?

AMP/1000, BUP/10, BZO/300, COC/300, FEN/1, MET/1000, MTD/300, OPI/300, OXY/100 and THC/50.

Does this 10 panel cup include fentanyl?

Yes. It has a dedicated fentanyl panel with a 1 ng/mL cutoff.

Does it include buprenorphine and methadone?

Yes. BUP/10 and MTD/300 are included, which makes it useful for treatment-program monitoring.

Is this cup CLIA waived?

Yes. This configuration is labeled CLIA-waived. The testing site still needs the appropriate CLIA certificate.

Can it be used for DOT testing?

No. Instant urine tests are not authorized for DOT-regulated drug testing under 49 CFR §40.210.

Do you offer bulk pricing?

Yes. Pricing drops with quantity, and orders of 100 cups or more ship free.